Phio Pharma Corp Live Stock Price Today, Share Analysis and Chart

Name: Phio Pharmaceuticals Corp: Is Infosys Ltd. worth buying?
Item: Phio Pharmaceuticals Corp
Rating: 1.28608325
Author: Trendlyne DVM scores

about

Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed to make immune cells more effective in killing tumor cells. Its pipeline programs are PH-762...

1.25 -0.05 (-3.85%)

70.17% Fall from 52W High

59,955

XNAS Volume

XNAS 09 Apr, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

14.3 / 100

Technically Neutral

37.1 / 100

No estimates available

Phio Pharma Corp Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Phio Pharma Corp Live Stock Price Today, Share Analysis and Chart

Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed to make immune cells more effective in killing tumor cells. Its pipeline programs are PH-762...

70.17% Fall from 52W High

SWOT Analysis

Phio Pharma Corp Live Price Chart